6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Nexans Mixed Shareholders’ Meeting of May 21st, 2026
Just now	Vertex Announces New Drug Submission for Suzetrigine Has Been Accepted for Review by Health Canada for the Treatment of Moderate-to-Severe Acute Pain in Adults
7m ago	AdvanSix : Celebrates Completion of Delaware River Dock Renovation at Frankford Facility
21m ago	Elis: Annual shareholders meeting of May 21, 2026
26m ago	New Jersey American Water Announces 2026 Volunteer Firefighter and EMS Grant Recipients

About

1.05USD-0.01 -0.48%

Closed • Updated at 17:33 GMT+00:00

Market Cap$5.44M

Volume12.2K

Beta-0.54

RSI28.45

Health TechnologyBiotechnology

Fibrobiologics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

FibroBiologics Files Patent Application for Oral Administration of Fibroblast Therapeutics

FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus

FibroBiologics Reports Preclinical Data Showing Fibroblast Spheroids May Actively Reprogram the Burn Wound Environment to Drive Healing and Reduce Scarring

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

FibroBiologics Reports Q1 2026 Financial Results and Provides Corporate Update

Community Chat

Ask AI